Baltimore health officials will be encouraging dialysis centers and HIV treatment clinics to review procedures for stopping the spread of drug-resistant staph infections in the wake of two new reports shedding light on the bacteria.
“MRSA has typically been a hospital issue,” Baltimore Health Department Commissioner Joshua Sharfstein said of methicillin-resistant staphylococcus aureus, the bacteria that cause sometimes-fatal skin infections.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.
